ERBB2 and breast cancer: In this MR analysis of up to 235,698 cancer cases and 333,932 controls, each copy of the GIPR E354Q missense variant was associated with a higher risk of overall, luminal A-like, and luminal B HER2 negative-like breast cancer risk.